Overview

A Study of LY3435151 in Participants With Solid Tumors

Status:
Terminated
Trial end date:
2020-03-05
Target enrollment:
Participant gender:
Summary
The reason for this study is to see if the study drug LY3435151 is safe in participants with advanced solid tumors.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Pembrolizumab